Pharmaceutical R&D spending rises but output falls says new report available at ReportBuyuer.com

R&D expenditure grew 6% CAGR from $26 billion in 2000 to $50 billion by the end of 2011. “Accelerating Drugs to Market – Despite Challenges, Adaptive Clinical Trials Reduce Drug Development Costs and Time to Market” http://www.reportbuyer.com …

Share